期刊文献+

水通道蛋白4和视神经脊髓炎 被引量:3

Aquaporin-4 and Neuromyelitis Optica
下载PDF
导出
摘要 视神经脊髓炎(neuromyelitis optica,NMO)是一种主要累及视神经和脊髓的复发性中枢神经系统炎性脱髓鞘病变,其主要病理特征为星形胶质细胞足板水通道蛋白-4(aquaporin-4,AQP4)缺失及激活补体在血管周围沉积。NMO免疫球蛋白G(NMO-immunoglobulin G,NMO-Ig G)是NMO的特异性血清学标记,NMO-Ig G与星形胶质细胞足板AQP4结合后介导的细胞毒性损伤是NMO的主要发病机制。NMO可以是一种独立疾病,也可以与结缔组织病并存。由于脊髓炎或视神经炎会导致患者永久性残疾或视力丧失,风湿科医师应采用必要的检查手段对容易复发或转变为NMO风险较大的患者及早做出诊断,对表现为脊髓炎或复发性视神经炎的结缔组织病患者应常规进行血清NMO-Ig G的检测。 Neuromyelitis optica (NMO) is a recurrent inflammatory demyelinating disorder of the central nervous system that mainly targets spinal cord and optic nerve,and is characterized by loss of aquaporin (AQP) 4 and perivascular deposition of activated complement.NMO-IgG is a specific serological marker of NMO,the combination of NMO-IgG with AQP-4 that mediated damage is the main pathogenesis of NMO.NMO may be an independent disease,but it can also be associated with connective tissue diseases.For the sake of potential permanent disability and sight loss following isolated attacks of myelitis or optic neuritis,rheumatologist should make great effort to identify individuals at risk for disease relapse or who are at risk for progression to full-spectrum NMO.We propose that AQP4-IgG testing should always be performed in patients with connective tissue diseases who present with myelitis or recurrent optic neuritis.
机构地区 中国医学科学院
出处 《中华临床免疫和变态反应杂志》 2014年第4期329-332,共4页 Chinese Journal of Allergy & Clinical Immunology
关键词 视神经脊髓炎 视神经脊髓炎免疫球蛋白G 水通道蛋白-4 结缔组织病 neuromyelitis optica neuromyelitis optica-immunoglobulin G aquaporin-4 connective tissue disease
  • 相关文献

参考文献17

  • 1Lennon VA,Wingerchuk DM,Kryzer TJ,et al.A serum autoantibody marker of neuromyelitis optica:distinction from multiple sclerosis[J].Lancet,2004,364:2106-2112.
  • 2Wingerchuk DM,Lennon VA,Pittock SJ,et al.Revised diagnostic criteria forneuromyelitis optica[J].Neurology,2006,66:1485-1489.
  • 3Kira J.Multiple sclerosis in the Japanrse population[J].Lancet Neuro,2003,2:117-127.
  • 4Zephir H,Faraday I,Outteryck O,et al.Is neuromyelitis optica associated with human leukocyte antigen?[J].Mult Scler,2009,15:571-579.
  • 5乔琳,罗妍,张丽丽,赵丽丹,王迁,徐雁,赵岩.原发性干燥综合征合并视神经脊髓炎11例临床分析[J].中华内科杂志,2013,52(9):745-748. 被引量:11
  • 6Kolfenbach JR,Horner BJ,Ferucci ED,et al.Neuromyelitis optica spectrum disorder in patients with connective tissue disease and myelitis[J].Arthritis Care Res(Hoboken),2011,63:1203-1208.
  • 7苏丽,沈敏,赵岩,张奉春.结缔组织病合并视神经脊髓炎八例临床分析[J].中华医学杂志,2013,93(3):226-227. 被引量:3
  • 8Wandinger KP,Stangel M,Witte T,et al.Autoantibodies against aquaporin-4 in patients with neuropsychiatric systemic lupus erythematosus and primary Sjgren’s syndrome[J].Arthritis Rheum,2010,62:1198-1200.
  • 9Phuan PW,Ratelade J,Rossi A,et al.Complementdependent cytotoxicity in neuromyelitis optica requires aquaporin-4 assembly in orthogonal arrays[J].J Biol Chem,2012,287:13829-13839.
  • 10Kitley J,Woodhall M,Waters P,et al.Myelinoligodendrocyte glycoprotein antibodies in adultswith a neuromyelitis optica phenotype[J].Neurology,2012,79:1273-1277.

二级参考文献19

  • 1费允云,张奉春.原发性干燥综合征中枢神经系统病变21例临床分析[J].中华风湿病学杂志,2007,11(8):479-482. 被引量:27
  • 2Wingerchuk DM, Hogancamp WF, O' Brien PC, et al. The clinical course of neuromyelitis optica (Devic' s syndrome ). Neurology, 1999, 53 : 1107-1114.
  • 3Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology, 2006, 66 : 1485 -1489.
  • 4Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemie lupus erythematosus. Arthritis Rheum, 1982, 25 : 1271-1277.
  • 5Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjgren's syndrome:a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis, 2002, 61:554-558.
  • 6Cross SA. Rethinking neuromyelitis optica (devic disease ). J Neuroophthalmol, 2007, 27:57-60.
  • 7Kahlenberg JM. Neuromyelitis optica spectrum disorder as an initial presentation of primary Sjogren's syndrome. Semin Arthritis Rheum,2011,40 : 343-348.
  • 8Wingerchuk DM, Lennon VA, Lueehinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol, 2007,6 : 805- 815.
  • 9Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis,2002,61:554-558.
  • 10Barendregt PJ, van den Bent MJ, van Raaij-van den Aaissen VJ, et al. Involvement of the peripheral nervous system in primary Sjogren's syndrome. Ann Rheum Dis,2001,60:876-881.

共引文献12

同被引文献29

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部